NeOnc Plans FDA Discussions On NEO212 Clinical Development And Potential Approval Pathway

India, Sept. 28 -- NeOnc Technologies Holdings, Inc. (NTHI) announced that it is scheduled to meet with the U.S. Food and Drug Administration (FDA) on November 17, 2026, for an in-person End-of-Phase ... Read More

Chugai Regains Rights To Emugrobart, Shifts Focus Back To SMA Development

India, Sept. 28 -- Chugai Pharmaceutical Co., Ltd. (4519) announced that development of Emugrobart (GYM329) for obesity has been discontinued, with all rights to the drug being returned by Roche (RHHB... Read More

Roche Plans Autonomous AI Labs To Accelerate Drug Discovery

India, Sept. 28 -- Swiss pharmaceutical Roche Holding AG (RHHBY) outlined plans on Monday to develop autonomous AI-driven laboratories as part of its efforts to accelerate research and development and... Read More

HCLSoftware To Acquire Robotic.ai

India, Sept. 28 -- On Monday, HCL Technologies Ltd. (HCLTECH.BO), an Indian IT company, announced that its subsidiary, HCLSoftware is planning to acquire Robotic.ai, a provider of Enterprise Robotic P... Read More

Akeso Enrolls First Patient In Phase 3 Cadonilimab Head-To-Head Gastric Cancer Trial

India, Sept. 28 -- Akeso, Inc. (9926.HK), a biopharmaceutical company, announced that it has enrolled the first patient in COMPASSION-37 (AK104-311), a phase 3 trial evaluating Cadonilimab as first-li... Read More

OSI System's Optoelectronics Division Receives $7 Mln In Orders For Electronic Sub-assemblies

India, Sept. 28 -- Monday, OSI Systems Inc (OSIS), a specialized electronic systems manufacturer, announced that its Optoelectronics and Manufacturing division has received orders of approximately $7 ... Read More

Citi Expands Coinbase Tie-up On Fiat-digital Payments

India, Sept. 28 -- Citigroup Inc. (C) announced on Monday that it has expanded its collaboration with Coinbase (COIN) to connect traditional banking with digital asset payments for corporations and co... Read More

Silexion Advances SIL204 With Positive Findings On Systemic Uptake In KRAS-Driven Cancers

India, Sept. 28 -- Silexion Therapeutics Corp. (SLXN) announced positive findings from an ongoing translational study evaluating the cellular uptake and gene-silencing mechanism of SIL204, its lead RN... Read More

Indian Shares Deep In Red As Financials Drag

India, Sept. 28 -- Indian shares were deep in the red on Monday after U.S. President Donald Trump rejected Iran's latest proposal to reopen the Strait of Hormuz and other demands. It was reported tha... Read More

Oncolytics Nears Interim Data Update From Randomized REO 033 Colorectal Cancer Study

India, Sept. 28 -- Oncolytics Biotech, Inc. (ONCY) announced continued clinical and operational progress in REO 033, a randomized study evaluating pelareorep in combination with FOLFIRI and bevacizuma... Read More

• «
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»